Us National Institutes Of Microbicide Trials Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Us national institutes of microbicide trials network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Us National Institutes Of Microbicide Trials Network Today - Breaking & Trending Today

South Africa Approves Dapivirine Vaginal Ring for Use by Women | International Partnership For Microbicides

First long-acting HIV prevention product designed specifically for womenApproval paves the way for the monthly ring’s introduction Nearly two-thirds of new adult HIV infections in South Africa occur among womenSILVER SPRING, Md. (March 11, 2022) The nonprofit International Partnership for Microbicides (IPM) today announced that the monthly dapivirine vaginal ring received ....

United States , United Kingdom , Silver Spring , Matabeleland North , South Africa , The Netherlands , South African , Tlaleng Mofokeng , Thesla Palanee Phillips , Linda Gail Bekker , Zeda Rosenberg , Yvette Raphael , Global Health Law , Melinda Gates Foundation , Janssen Pharmaceutical Companies Of Johnson , Wits Reproductive Health , United States Agency For International Development , National Department Of Health , International Partnership For Microbicides , Oneill Institute For National , International Women Day , Kfw Development Bank , Janssen Sciences Ireland Unlimited Company , Danish Ministry Of Foreign Affairs , Ministry Of Foreign Affairs The Netherlands , Desmond Tutu Health Foundation ,

IPM's New Drug Application for Dapivirine Vaginal Ring to Reduce HIV Risk in Women Accepted for Filing by US Food and Drug Administration

IPM’s New Drug Application for Dapivirine Vaginal Ring to Reduce HIV Risk in Women Accepted for Filing by US Food and Drug Administration
IPM’s New Drug Application for Dapivirine Vaginal Ring to Reduce HIV Risk in Women Accepted for Filing by US Food and Drug Administration
SILVER SPRING, Md. (March 3, 2021) The nonprofit International Partnership for Microbicides (IPM) announced today that the US Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for the monthly dapivirine vaginal ring, designed to reduce the risk of HIV-1 infection through vaginal sex.
Made of flexible silicone, the investigational product releases an antiretroviral drug (ARV) called dapivirine over the course of one month. Women can insert and replace the ring themselves. IPM designed the ring to offer women a discreet and long-acting HIV prevention choice that they can control themselves. ....

United States , United Kingdom , South Africa , Silver Spring , Matabeleland North , The Netherlands , Zedaf Rosenberg , German Federal Ministry Of Education , European Medicines Agency Under Article , World Health Organization , Drug Administration , Melinda Gates Foundation , Janssen Pharmaceutical Companies Of Johnson , United States Agency For International Development , Janssen Sciences Ireland , Us National Institutes Of Microbicide Trials Network , International Partnership For Microbicides , Kfw Development Bank , Commonwealth Development Office , Danish Ministry Of Foreign Affairs , Ministry Of Foreign Affairs The Netherlands , International Partnership , New Drug Application , Ring Study , Health Funded Microbicide Trials Network , Janssen Pharmaceutical Companies ,

IPM Welcomes WHO's Recommendation for Dapivirine Vaginal Ring as New Women's HIV Prevention Option | International Partnership For Microbicides

IPM Welcomes WHO’s Recommendation for Dapivirine Vaginal Ring as New Women’s HIV Prevention Option
IPM Welcomes WHO’s Recommendation for Dapivirine Vaginal Ring as New Women’s HIV Prevention Option
WHO recommends the monthly ring be offered as part of a combination prevention approach for women at substantial HIV risk
SILVER SPRING, Md. (January 27, 2021) The nonprofit International Partnership for Microbicides (IPM) welcomes today’s recommendation by the World Health Organization (WHO) that the monthly dapivirine ring may be offered as an additional prevention choice for women at substantial risk of HIV infection. The WHO’s recommendation supports expanding the prevention portfolio with the first long-acting option that a woman could control herself and use discreetly to reduce her HIV risk during vaginal sex, pending regulatory approvals for the product. ....

United States , United Kingdom , South Africa , The Netherlands , Zedaf Rosenberg , European Medicines Agency Under Article , Melinda Gates Foundation , Janssen Pharmaceutical Companies Of Johnson , United States Agency For International Development , Guideline Development Group , Janssen Sciences Ireland , International Partnership For Microbicides , Kfw Development Bank , Danish Ministry Of Foreign Affairs , Ministry Of Foreign Affairs The Netherlands , German Federal Ministry Of Education , Drug Administration , World Health Organization , Us National Institutes Of Microbicide Trials Network , Commonwealth Development Office , International Partnership , European Medicines Agency , Health Funded Microbicide Trials Network , Saharan Africa , Danish Ministry , Foreign Affairs ,